Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Schizophrenia Research|September 26, 2022
Paratonia, Gegenhalten and psychomotor hypertonia Back to the rootsJack R Foucher, Ludovic C Dormegny-Jeanjean, Andreas J Bartsch, et al.
Internet Interventions|April 15, 2024
Efficacy of the my health too online cognitive behavioral therapy program for healthcare workers during the COVID-19 pandemic: A randomized controlled trialAmaury C Mengin, Nathalie Nourry, François Severac, et al.
Frontiers in Psychiatry|October 13, 2023
Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial - CADOTLudovic Christophe Dormegny-Jeanjean, Clément de Billy, Olivier Mainberger, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 17, 2021
Handedness as a neurodevelopmental marker in schizophrenia: Results from the FACE-SZ cohortJasmina Mallet, Ophélia Godin, Yann Le Strat, et al.
Schizophrenia Research|June 27, 2018
Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) scalePaul Roux, Mathieu Urbach, Sandrine Fonteneau, et al.
Clinical Rehabilitation|July 18, 2018
Screening for cognitive deficits with the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scalePaul Roux, Mathieu Urbach, Sandrine Fonteneau, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 30, 2022
History of learning disorders is associated with worse cognitive and functional outcomes in schizophrenia: results from the multicentric FACE-SZ cross-sectional datasetClément Dondé, Caroline Dubertret, Guillaume Fond, et al.
Research Square|January 23, 2024
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysisMichele Fornaro, Claudio Caiazza, Martina Billeci, et al.
Translational Psychiatry|November 7, 2023
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ datasetDavid Misdrahi, Maud Dupuy, Yecodji Dansou, et al.
Molecular Psychiatry|July 18, 2024
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis "Nutra NMA SCZ"Michele Fornaro, Claudio Caiazza, Martina Billeci, et al.
Pageof 14